Co-activation and Muscle Weakness in Neurological Disorders
Author Information
Author(s): Busse Monica E, Wiles Charles M, van Deursen Robert WM
Primary Institution: Cardiff University
Hypothesis
Antagonist co-activation would not be related to muscle strength per se but would be dependent on the site of the neurological lesion causing weakness.
Conclusion
Co-activation levels did not appear to vary systematically between diagnostic neurology groups when compared to healthy subjects, with the possible exception of extra-pyramidal disorder where co-activation tended to be lower.
Supporting Evidence
- Co-activation levels in healthy subjects were approximately 11.8% during isometric knee extension.
- Patients with extrapyramidal disorders showed significantly lower co-activation levels compared to healthy controls.
- Correlation between muscle strength and co-activation was significant only in muscle disease patients.
Takeaway
This study looked at how muscles work together in people with different neurological problems. It found that muscle co-activation doesn't change much between healthy people and those with certain conditions.
Methodology
The study compared five groups of patients with different neurological disorders to a control group, measuring muscle strength and co-activation during isometric contractions and functional tasks.
Limitations
The study excluded patients who were very weak or unable to walk the required distance, which may limit the generalizability of the findings.
Participant Demographics
Participants included 74 neurology patients with various conditions and 32 healthy controls, matched for age and gender.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website